Maze Therapeutics (MAZE) Financials: Revenue & Earnings
MAZE$31.47-0.22 -0.69%
$1.75B
Market Cap
-11.57
P/E
—
Forward P/E
64
Score
Maze Therapeutics (MAZE) Financials: Revenue & Earnings
MAZE price $31.47 -0.22 -0.69%
- Ticker
- MAZE
- Price
- $31.47
- Change
- -0.22 -0.69%
- Market cap ?
- $1.75B
- P/E ?
- -11.57
- Dividend yield ?
- 0.00%
- Beta ?
- 2.15
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 64
- Value
- 56
- Quality
- 37
- Growth
- 100
Stocklytics score rationale: value 56, quality 37, growth 100.
Financials
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| 0 | 0 | 167500000 | 0 |
Maze Therapeutics, Inc., a clinical stage biopharmaceutical company, develops small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States. Its lead programs include MZE829, an oral small molecule inhibitor of apolipoprotein L1, or APOL1, which is in phase II clinical trial for the treatment of patients with APOL1 kidney disease; and MZE782, an oral small molecule…
Fair value
MAZE fair value Not meaningful. Price $31.47.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful. The model is more than 80% below the live price, which happens for unprofitable or very early companies and is not a price target.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-05 | — | -0.76 | — | 333.33K |
| 2026-08-12 | -0.76 | -0.72 | — | 2.86M |
| 2026-05-12 | -0.45 | -0.43 | 20.00M | 10.62M |
| 2026-03-25 | -0.65 | -0.73 | — | 375.00K |
| 2025-11-06 | -0.66 | -0.74 | — | — |
| 2025-08-12 | -0.77 | -0.79 | — | 3.12M |
| 2025-05-14 | -1.15 | -0.76 | — | — |
| 2025-03-31 | -18.32 | 0.45 | — | — |
| 2024-12-06 | -0.06 | — | 2.50M | — |
| 2024-06-30 | 3.18 | — | 165.00M | — |
| 2024-03-31 | -0.74 | — | — | — |
| 2023-12-31 | -0.61 | — | — | — |
| 2023-09-30 | -0.57 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-01 | Coloma Jason V | Sell | 31.91K | $27.02 | 862.19K |
| 2026-10-01 | Coloma Jason V | Sell | 2.59K | $27.02 | 70.07K |
| 2026-10-01 | Bernstein Harold | Sell | 16.14K | $10.42 | 168.19K |
| 2026-10-01 | Bernstein Harold | Buy | 16.14K | $10.42 | 168.19K |
| 2026-10-01 | Bernstein Harold | Sell | 16.14K | $26.93 | 434.74K |
| 2026-09-29 | Dandekar Atul | Buy | 7.50K | $10.42 | 78.15K |
| 2026-09-29 | Dandekar Atul | Sell | 7.50K | $27.06 | 202.92K |
| 2026-09-29 | Dandekar Atul | Sell | 7.50K | $10.42 | 78.15K |
| 2026-09-04 | Bernstein Harold | Sell | 9.71K | $26.22 | 254.50K |
| 2026-09-03 | Courtney Phillips | Sell | 1.99K | $26.01 | 51.77K |
| 2026-09-03 | Courtney Phillips | Sell | 22 | $25.78 | 567 |
| 2026-09-03 | Dandekar Atul | Sell | 3.21K | $26.01 | 83.42K |
| 2026-09-03 | Dandekar Atul | Sell | 36 | $25.81 | 929 |
| 2026-09-03 | Coloma Jason V | Sell | 11.28K | $26.01 | 293.48K |
| 2026-09-03 | Coloma Jason V | Sell | 129 | $25.77 | 3.32K |
| 2026-09-03 | Bernstein Harold | Sell | 5.13K | $26.01 | 133.45K |
| 2026-09-03 | Bernstein Harold | Sell | 59 | $25.78 | 1.52K |
| 2026-09-02 | Courtney Phillips | Sell | 1.74K | $26.38 | 45.84K |
| 2026-09-02 | Courtney Phillips | Sell | 243 | $27.12 | 6.59K |
| 2026-09-02 | Dandekar Atul | Sell | 2.80K | $26.38 | 73.85K |
| 2026-09-02 | Dandekar Atul | Sell | 391 | $27.12 | 10.60K |
| 2026-09-02 | Coloma Jason V | Sell | 9.85K | $26.38 | 259.86K |
| 2026-09-02 | Coloma Jason V | Sell | 1.38K | $27.12 | 37.29K |
| 2026-09-02 | Bernstein Harold | Sell | 4.48K | $26.38 | 118.19K |
| 2026-09-02 | Bernstein Harold | Sell | 625 | $27.12 | 16.95K |
| 2026-09-01 | Courtney Phillips | Buy | 11.00K | — | — |
| 2026-09-01 | Courtney Phillips | Sell | 11.00K | — | — |
| 2026-09-01 | Dandekar Atul | Buy | 12.50K | — | — |
| 2026-09-01 | Dandekar Atul | Sell | 12.50K | — | — |
| 2026-09-01 | Coloma Jason V | Sell | 31.91K | $26.29 | 838.78K |
| 2026-09-01 | Coloma Jason V | Buy | 50.00K | — | — |
| 2026-09-01 | Coloma Jason V | Sell | 50.00K | — | — |
| 2026-09-01 | Coloma Jason V | Sell | 2.59K | $26.31 | 68.21K |
| 2026-09-01 | Bernstein Harold | Sell | 16.14K | $10.42 | 168.19K |
| 2026-09-01 | Bernstein Harold | Buy | 20.00K | — | — |
| 2026-09-01 | Bernstein Harold | Sell | 20.00K | — | — |
| 2026-09-01 | Bernstein Harold | Buy | 16.14K | $10.42 | 168.19K |
| 2026-09-01 | Bernstein Harold | Sell | 16.14K | $26.36 | 425.51K |
| 2026-08-28 | Dandekar Atul | Buy | 7.50K | $10.42 | 78.15K |
| 2026-08-28 | Dandekar Atul | Sell | 7.50K | $27.58 | 206.82K |
| 2026-08-28 | Dandekar Atul | Sell | 7.50K | $10.42 | 78.15K |
| 2026-08-13 | Kornowski Sophie | Buy | 36.00K | $27.66 | 995.94K |
| 2026-08-13 | Johnson Paula A | Buy | 36.00K | $27.66 | 995.94K |
| 2026-08-13 | Kornowski Sophie | Other | 0 | — | — |
| 2026-08-13 | Johnson Paula A | Other | 0 | — | — |
| 2026-08-13 | Bernstein Harold | Sell | 16.14K | $10.42 | 168.20K |
| 2026-08-13 | Bernstein Harold | Buy | 16.14K | $10.42 | 168.20K |
| 2026-08-13 | Bernstein Harold | Sell | 16.14K | $27.61 | 445.62K |
| 2026-08-03 | Coloma Jason V | Sell | 30.30K | $26.71 | 809.54K |
| 2026-08-03 | Coloma Jason V | Sell | 1.60K | $27.09 | 43.44K |
| 2026-08-03 | Coloma Jason V | Sell | 2.44K | $26.71 | 65.16K |
| 2026-08-03 | Coloma Jason V | Sell | 154 | $27.09 | 4.17K |
| 2026-07-29 | Dandekar Atul | Buy | 7.50K | $10.42 | 78.15K |
| 2026-07-29 | Dandekar Atul | Sell | 7.10K | $27.31 | 193.88K |
| 2026-07-29 | Dandekar Atul | Sell | 400 | $27.89 | 11.16K |
| 2026-07-29 | Dandekar Atul | Sell | 7.50K | $10.42 | 78.15K |
| 2026-07-01 | Bernstein Harold | Sell | 14.61K | $10.42 | 152.23K |
| 2026-07-01 | Bernstein Harold | Buy | 14.61K | $10.42 | 152.23K |
| 2026-07-01 | Bernstein Harold | Sell | 13.41K | $29.86 | 400.46K |
| 2026-07-01 | Bernstein Harold | Sell | 1.20K | $30.34 | 36.40K |
| 2026-07-01 | Coloma Jason V | Sell | 30.31K | $29.95 | 907.92K |
| 2026-07-01 | Coloma Jason V | Sell | 1.60K | $30.44 | 48.61K |
| 2026-07-01 | Coloma Jason V | Sell | 2.59K | $29.98 | 77.73K |
| 2026-06-29 | Dandekar Atul | Buy | 7.50K | $10.42 | 78.15K |
| 2026-06-29 | Dandekar Atul | Sell | 7.50K | $10.42 | 78.15K |
| 2026-06-29 | Dandekar Atul | Sell | 7.50K | $28.02 | 210.15K |
| 2026-06-23 | Coloma Jason V | Sell | 23.86K | $26.05 | 621.67K |
| 2026-06-22 | Coloma Jason V | Sell | 1.95K | $26.00 | 50.78K |
| 2026-06-22 | Coloma Jason V | Sell | 2.04K | $26.00 | 53.04K |
| 2026-06-08 | SPIEGELMAN DANIEL K | Buy | 18.00K | $23.58 | 424.44K |
| 2026-06-08 | SCHELLER RICHARD H | Buy | 18.00K | $23.58 | 424.44K |
| 2026-06-08 | Lim Jonathan E | Buy | 18.00K | $23.58 | 424.44K |
| 2026-06-08 | Hoppenot Herve | Buy | 18.00K | $23.58 | 424.44K |
| 2026-06-08 | HOMCY CHARLES J | Buy | 18.00K | $23.58 | 424.44K |
| 2026-06-08 | Andrews Nancy C | Buy | 18.00K | $23.58 | 424.44K |
| 2026-06-01 | Coloma Jason V | Sell | 6.09K | $26.20 | 159.54K |
| 2026-06-01 | Coloma Jason V | Sell | 553 | $26.24 | 14.51K |
| 2026-06-01 | Bernstein Harold | Sell | 14.85K | $10.42 | 154.77K |
| 2026-06-01 | Bernstein Harold | Buy | 14.85K | $10.42 | 154.77K |
| 2026-06-01 | Bernstein Harold | Sell | 13.25K | $25.57 | 338.94K |
| 2026-06-01 | Bernstein Harold | Sell | 1.60K | $26.36 | 42.17K |
| 2026-05-29 | Dandekar Atul | Sell | 7.50K | $10.42 | 78.15K |
| 2026-05-29 | Dandekar Atul | Buy | 7.50K | $10.42 | 78.15K |
| 2026-05-29 | Dandekar Atul | Sell | 7.50K | $26.34 | 197.55K |
| 2026-05-26 | Coloma Jason V | Sell | 25.58K | $26.02 | 665.52K |
| 2026-05-22 | Coloma Jason V | Sell | 4.50K | $26.00 | 117.10K |
| 2026-05-22 | Coloma Jason V | Sell | 2.48K | $26.00 | 64.43K |
| 2026-05-15 | Coloma Jason V | Sell | 1.82K | $26.00 | 47.37K |
| 2026-05-15 | Coloma Jason V | Sell | 116 | $26.00 | 3.02K |
| 2026-05-14 | Bernstein Harold | Sell | 15.00K | $10.42 | 156.30K |
| 2026-05-14 | Bernstein Harold | Buy | 15.00K | $10.42 | 156.30K |
| 2026-05-14 | Bernstein Harold | Sell | 15.00K | $26.22 | 393.35K |
| 2026-05-04 | Dandekar Atul | Sell | 5.99K | $10.42 | 62.36K |
| 2026-05-04 | Dandekar Atul | Buy | 5.99K | $10.42 | 62.36K |
| 2026-05-04 | Dandekar Atul | Sell | 8.32K | $10.42 | 86.69K |
| 2026-05-04 | Dandekar Atul | Buy | 8.32K | $10.42 | 86.69K |
| 2026-05-04 | HOMCY CHARLES J | Sell | 7.42K | — | — |
| 2026-04-29 | Dandekar Atul | Sell | 7.50K | $10.42 | 78.15K |
| 2026-04-29 | Dandekar Atul | Buy | 7.50K | $10.42 | 78.15K |
| 2026-04-29 | Dandekar Atul | Sell | 7.50K | $25.37 | 190.30K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 169, holders -7 vs prior quarter. Ownership 99.66%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 5.03M | 465.64K | +10.20% | 150.18M |
| TRV GP IV, LLC | 4.47M | 0 | 0.00% | 133.50M |
| ARCH VENTURE MANAGEMENT, LLC | 4.12M | 0 | 0.00% | 122.98M |
| DEEP TRACK CAPITAL, LP | 3.73M | 255.01K | +7.33% | 111.38M |
| BLACKROCK, INC. | 3.50M | 932.42K | +36.27% | 104.52M |
| JUPITER TOPCO LLC | 3.41M | 3.41M | New | 101.76M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.60M | 2.60M | New | 77.69M |
| LOGOS GLOBAL MANAGEMENT LP | 1.94M | 700.00K | +56.68% | 57.74M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.78M | 342.57K | +23.86% | 53.06M |
| A16Z CAPITAL MANAGEMENT, L.L.C. | 1.70M | 0 | 0.00% | 50.79M |
| VENROCK ADVISER, LLC | 1.60M | 0 | 0.00% | 47.80M |
| ALPHABET INC. | 1.39M | 0 | 0.00% | 41.44M |
| BRAIDWELL LP | 1.14M | 1.14M | New | 34.02M |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 1.11M | 734.81K | +197.00% | 33.06M |
| FMR LLC | 1.06M | 192.75K | +22.30% | 31.54M |
| GENERAL CATALYST GROUP MANAGEMENT, LLC | 1.04M | 0 | 0.00% | 30.91M |
| STATE STREET CORP | 997.53K | 360.81K | +56.67% | 29.77M |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 954.89K | 318.72K | +50.10% | 28.49M |
| TRV GP V, LLC | 950.80K | 0 | 0.00% | 28.37M |
| JPMORGAN CHASE & CO | 964.01K | 905.57K | +1549.40% | 28.00M |
| MARSHALL WACE, LLP | 914.57K | 603.93K | +194.42% | 27.29M |
| GEODE CAPITAL MANAGEMENT, LLC | 858.05K | 258.09K | +43.02% | 25.61M |
| CITADEL ADVISORS LLC | 852.68K | 827.78K | +3324.40% | 25.44M |
| CASDIN CAPITAL, LLC | 843.86K | 85.00K | +11.20% | 25.18M |
| ARROWMARK COLORADO HOLDINGS LLC | 767.38K | 0 | 0.00% | 22.90M |
Earnings and financials
Maze Therapeutics, Inc. (MAZE) trades at $31.47, with a market cap of $1.75B and a trailing P/E of -11.57. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|
| 0 | 0 | 167500000 | 0 |
Insights · Dividends · Forecast · Financials · Learn